PRP Hair Therapy Shows Years of Lasting Gains in a 10-Year Study
Evidence review & editorial synthesis
If you are thinning at the crown, temples, or part line, can a short course of your own platelet-rich plasma do more than create a brief cosmetic bump? A new 10-year prospective study suggests it may. After three monthly PRP sessions, 234 men and women with androgenetic alopecia had 31.4% higher hair density at 12 months. Average density remained 24.1% above baseline at three years and 17.3% above baseline at five years. The surprise is not just the early rise. It is that measurable benefit persisted for years, while patients receiving maintenance treatment were still above baseline at the 10-year mark.
Three sessions produced a surprisingly durable signal
The new Aesthetic Surgery Journal study followed 234 people with androgenetic alopecia, including 135 men with Norwood-Hamilton stage I to IV hair loss and 99 women with Ludwig stage I to II hair loss. Participants received three sessions of autologous non-activated platelet-rich plasma, or A-PRP, at 30-day intervals. The PRP was injected intradermally at 0.2 mL per square centimeter.
Researchers used computerized trichoscopy and phototrichograms to track hair density, hair thickness, and total hair count. At 12 months, hair density was up 31.4%, hair thickness 26.8%, and total hair count 29.7% from baseline. Density then declined gradually but remained clearly above baseline at three years, up 24.1%, and five years, up 17.3%.
At 10 years, patients receiving maintenance treatment still showed an 11.2% improvement. Women also showed greater preservation of hair-shaft diameter, and the study reported no severe adverse events. For a treatment often studied for only a few months, the long follow-up is the most important part of the story.
Why PRP may be more than a short-lived boost
PRP is made from a patient's own blood. After processing, the platelet-rich fraction is injected back into the scalp. Platelets release signaling molecules and growth factors that can influence follicular activity, blood-vessel formation, and dermal papilla cells, which help regulate the hair-growth cycle.
That does not mean PRP creates entirely new follicles. A more realistic goal is to improve the performance of follicles that are still present but progressively miniaturizing in androgenetic alopecia. In practical terms, that could mean thicker coverage, more hairs per measured area, and slower visible progression for some patients.
The durability in the new study is especially encouraging because pattern hair loss is chronic. A treatment that produces a noticeable bump for several months is useful, but a strategy that can preserve part of that gain over several years has a very different value proposition. It begins to look less like a cosmetic event and more like long-term follicle maintenance.
The wider evidence is moving in the same direction
The new paper is not standing alone. A 2025 systematic review and meta-analysis examined 43 randomized trials involving 1,877 participants with alopecia. The authors concluded that the evidence was moderate for PRP improving hair density, reducing hair loss, and improving clinical outcomes and satisfaction. Importantly, that review also found that preparation and activation protocols matter, which fits the new study's emphasis on standardized delivery.
An independent 2024 meta-analysis of randomized trials also found higher hair density with PRP than placebo, with an average difference of 27.55 hairs per square centimeter. That analysis rated the evidence as low quality because the studies were highly heterogeneous and showed publication bias. The direction of the evidence is therefore increasingly positive, even if the field is not yet as standardized as it needs to be.
There is also early evidence that PRP may work as an add-on rather than an either-or alternative. A 2024 meta-analysis of five randomized trials found better short-term hair-density outcomes when injectable PRP was added to topical minoxidil than with minoxidil alone, although the certainty was low to very low.
What the 10-year result really means
The headline should not be read as three injections lasting untouched for a decade. The accessible abstract reports an 11.2% improvement at 120 months specifically in patients receiving maintenance treatment. It does not specify in the abstract how often that maintenance was given, how many participants remained at every time point, or the details of the randomized comparison.
That distinction matters, but it does not erase the encouraging part. The reported five-year analysis still showed hair density 17.3% above baseline, which is already unusually long follow-up for this field. The 10-year maintenance result then suggests that ongoing treatment may preserve at least part of the benefit over a much longer horizon.
The paper is currently an accepted manuscript, meaning it has passed peer review but has not yet been replaced by the final typeset version. Its DOI will remain the same.
A more hopeful way to think about PRP
PRP is not a cure for genetic hair loss, and it will not replace every established option. But the evidence is becoming harder to dismiss as a short-term novelty. The most plausible future role may be as a repeatable maintenance therapy, alone or combined with treatments such as minoxidil, for people who still have viable miniaturizing follicles and want to preserve density without moving directly to hair transplantation.
For someone considering PRP, the practical questions are increasingly about protocol rather than whether the concept has any signal at all: How is the PRP prepared? Is the process standardized? What dose is injected per area? How is response measured? What maintenance schedule is recommended? And is the clinic tracking objective hair density rather than relying only on photographs?
Those details could determine whether results in the real world resemble the better clinical studies. The new 10-year data do not close the case, but they make a genuinely hopeful point: with a standardized approach and continued maintenance, PRP may be capable of preserving meaningful hair-density gains for years, not just months.
Scientific References & Further Reading
- Anchor Study: “Long-term Clinical Outcomes of Autologous Non-activated Platelet-rich Plasma (A-PRP) Delivered Through Mechanical and Controlled Infiltration in Male and Female Androgenetic Alopecia: A 10-year Prospective Randomized Evaluator-blinded Study.” (Gentile P. Aesthetic Surgery Journal. Published online September 2, 2026. doi:10.1093/asj/sjag181.)
- Systematic Review and Meta-analysis: “Platelet-Rich Plasma in the Management of Alopecia: A Systematic Review and Meta-Analysis of Clinical Evidence.” (Anitua E, Tierno R, Alkhraisat MH. Dermatology and Therapy. 2025;15(11):3213-3252. doi:10.1007/s13555-025-01542-8.)
- Randomized-Trial Meta-analysis: “Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials.” (Kieling L, Konzen AT, Zanella RK, Valente DS. Anais Brasileiros de Dermatologia. 2024;99(6):847-862. doi:10.1016/j.abd.2024.01.002.)
- Combination-Therapy Meta-analysis: “The additive value of platelet-rich plasma to topical Minoxidil in the treatment of androgenetic alopecia: A systematic review and meta-analysis.” (Yao J, Zhu L, Pan M, et al. PLOS ONE. 2024;19(8):e0308986. doi:10.1371/journal.pone.0308986.)
Disclaimer: This article is for informational purposes only and does not constitute medical advice. It is not a substitute for diagnosis, treatment, or individualized medical care.

